{
    "hands_on_practices": [
        {
            "introduction": "A major complication of myocardial infarction is the structural weakening of the heart wall, leading to dangerous remodeling and the potential for a ventricular aneurysm. By applying Laplace’s Law, a fundamental principle from physics, we can quantify the dramatic increase in wall stress that occurs when an infarcted segment thins and dilates. This exercise provides a powerful quantitative insight into the mechanical forces that drive this pathological process. ",
            "id": "4411673",
            "problem": "A patient suffers an acute transmural myocardial infarction (MI) of the anterior wall. In the hours following the infarction, the infarcted segment becomes mechanically weakened and thins, while the chamber radius in that region increases slightly. Model the left ventricle as a spherical pressure chamber at end systole. Assume the following physiologically realistic parameters: before infarction, the end-systolic internal radius is $2.5\\,\\text{cm}$ and the wall thickness is $1.2\\,\\text{cm}$; after early infarct thinning and regional dilation, the local end-systolic internal radius in the affected region is $3.0\\,\\text{cm}$ and the wall thickness is $0.6\\,\\text{cm}$. Assume the end-systolic intraventricular pressure remains approximately constant at $16\\,\\text{kPa}$ over this short time frame.\n\nUsing the force-balance relationship captured by Laplace’s law for a spherical cardiac chamber, estimate the fold-change in circumferential wall stress in the infarcted region from the pre-infarction state to the thinned, dilated state. Express your result as a pure number (dimensionless). Round your answer to four significant figures.",
            "solution": "The goal is to determine how circumferential wall stress changes when the chamber radius increases and the wall thickness decreases after myocardial infarction (MI). The appropriate fundamental base is the mechanical equilibrium of a thin-walled spherical pressure vessel, which can be derived from first principles by balancing forces across a hemispherical cut.\n\nConsider a spherical chamber of internal radius $r$, wall thickness $h$, and internal pressure $P$. Take a hemispherical section and examine equilibrium at the equator. The net force due to internal pressure acting to separate the hemispheres equals the pressure times the projected area,\n$$\nF_{\\text{pressure}} = P \\cdot \\pi r^{2}.\n$$\nThis force is balanced by the resisting force generated by circumferential (hoop) wall stress $\\sigma$ distributed over the wall cross-sectional area around the equator. The total resisting force along the equator is the stress times the cross-sectional area of the equatorial ring, which is circumference times thickness,\n$$\nF_{\\text{wall}} = \\sigma \\cdot (2\\pi r h).\n$$\nStatic equilibrium requires $F_{\\text{pressure}} = F_{\\text{wall}}$, hence\n$$\nP \\pi r^{2} = \\sigma (2\\pi r h) \\quad \\Longrightarrow \\quad \\sigma = \\frac{P r}{2 h}.\n$$\nThis is the spherical form of Laplace’s law for wall stress. It shows that, at fixed pressure, wall stress is directly proportional to radius and inversely proportional to wall thickness. Therefore, thinning of the infarcted wall ($h$ decreases) and regional dilation ($r$ increases) both increase $\\sigma$, which provides a mechanistic explanation for the propensity of a weakened infarcted segment to bulge outward and form a ventricular aneurysm.\n\nWe are asked for the fold-change in wall stress from the pre-infarction state to the thinned, dilated state. Denote pre-infarction quantities by the subscript $0$ and post-infarction quantities by the subscript $1$. The fold-change is\n$$\n\\frac{\\sigma_{1}}{\\sigma_{0}} = \\frac{\\frac{P r_{1}}{2 h_{1}}}{\\frac{P r_{0}}{2 h_{0}}} = \\frac{r_{1} h_{0}}{r_{0} h_{1}},\n$$\nwhere the pressure $P$ and the factor $2$ cancel, as assumed constant over the short time frame.\n\nSubstitute the given values (converting all lengths consistently, though the ratio is unitless and identical whether one uses centimeters or meters):\n- $r_{0} = 2.5\\,\\text{cm}$,\n- $h_{0} = 1.2\\,\\text{cm}$,\n- $r_{1} = 3.0\\,\\text{cm}$,\n- $h_{1} = 0.6\\,\\text{cm}$.\n\nCompute:\n$$\n\\frac{\\sigma_{1}}{\\sigma_{0}} = \\frac{(3.0)(1.2)}{(2.5)(0.6)} = \\frac{3.6}{1.5} = 2.4.\n$$\n\nRounded to four significant figures, the fold-increase is $2.400$. This quantitative increase in wall stress reflects the combined destabilizing effects of increased radius and decreased thickness in the infarcted wall segment, providing a mechanistic basis for aneurysm formation in myocardial infarction pathology.",
            "answer": "$$\\boxed{2.400}$$"
        },
        {
            "introduction": "While many myocardial infarctions result from an acute coronary thrombus (Type 1 MI), a significant number arise from an imbalance between myocardial oxygen supply and demand. This practice challenges you to derive the formal criteria for this \"Type 2 MI\" from fundamental physiological principles governing oxygen delivery and cardiac workload. Mastering this distinction is essential for accurate diagnosis and for appreciating the diverse pathophysiology of myocardial injury. ",
            "id": "4411694",
            "problem": "An adult patient presents with acute chest discomfort during a rapid supraventricular tachycardia. Laboratory evaluation shows a rise and subsequent fall in Cardiac Troponin (cTn), with peak values above the ninety-ninth percentile upper reference limit. There is no angiographic evidence of an acute coronary thrombus. Hemoglobin is reduced, and pulse oximetry indicates mild hypoxemia. Electrocardiography (ECG) demonstrates transient ischemic changes. To formalize the diagnosis category mechanistically, begin from a physiology base in which myocardial oxygen delivery and consumption are related by Fick’s principle and standard hemodynamic proxies.\n\nFundamental base:\n- Myocardial oxygen delivery $DO_2$ depends on coronary blood flow $Q$ and arterial oxygen content $C_{a}O_2$, such that $DO_2 = Q \\times C_{a}O_2$.\n- Arterial oxygen content can be expressed as $C_{a}O_2 = 1.34 \\times [Hb] \\times S_{a}O_2 + 0.003 \\times P_{a}O_2$, where $[Hb]$ is hemoglobin concentration, $S_{a}O_2$ is arterial oxygen saturation, and $P_{a}O_2$ is arterial partial pressure of oxygen.\n- Myocardial oxygen consumption $MVO_2$ increases with cardiac workload, which can be approximated by the rate–pressure product $HR \\times SBP$, where $HR$ is heart rate and $SBP$ is systolic blood pressure, reflecting tension–time index and afterload determinants of ventricular work.\n\nWithin this framework, ischemia results when $MVO_2 > DO_2$ in a coronary territory. Myocardial infarction requires evidence of myocardial necrosis and ischemia. According to core pathology, myocardial necrosis in this context is evidenced by a rise and/or fall of Cardiac Troponin (cTn) with at least one value above the $99^{\\mathrm{th}}$ percentile upper reference limit, together with ischemic features (symptoms, ECG changes, or imaging evidence), whereas the mechanism distinguishes categories. Acute coronary atherothrombosis (plaque rupture with intraluminal thrombus) is the hallmark mechanism for one category, and a primary supply–demand mismatch without acute atherothrombosis is the hallmark mechanism for another.\n\nA cohort scenario illustrates the supply–demand imbalance: suppose $[Hb] = 8\\,\\mathrm{g/dL}$, $S_{a}O_2 = 0.90$, $P_{a}O_2 = 60\\,\\mathrm{mmHg}$, and a transient tachyarrhythmia with $HR = 160\\,\\mathrm{beats/min}$ and $SBP = 110\\,\\mathrm{mmHg}$. The oxygen content $C_{a}O_2$ is thereby reduced compared with typical values at $[Hb] \\approx 15\\,\\mathrm{g/dL}$ and $S_{a}O_2 \\approx 0.98$, while the workload proxy $HR \\times SBP$ is increased. If no acute intraluminal thrombus is present, yet there is objective ischemia with cTn dynamics as above, the mechanism implies an imbalance rather than acute plaque rupture.\n\nBased on this derivation from first principles, which option correctly enumerates the diagnostic criteria that define the category of myocardial infarction driven by supply–demand mismatch without acute coronary atherothrombosis?\n\nA. Rise and/or fall in Cardiac Troponin (cTn) with at least one value above the $99^{\\mathrm{th}}$ percentile upper reference limit, plus objective evidence of myocardial ischemia (ischemic symptoms, new ischemic ECG changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormality), and identification of a precipitating condition that causes myocardial oxygen supply–demand imbalance (for example anemia, hypoxemia, tachyarrhythmia, hypotension or severe hypertension), occurring without angiographic or pathological evidence of acute coronary atherothrombosis (no plaque rupture or intraluminal coronary thrombus).\n\nB. Any elevation of Cardiac Troponin (cTn) above the $99^{\\mathrm{th}}$ percentile upper reference limit, even if stable over time, without requiring ischemic symptoms or objective ischemic findings; mechanism unspecified and independent of supply–demand considerations.\n\nC. Rise and/or fall in Cardiac Troponin (cTn) above the $99^{\\mathrm{th}}$ percentile upper reference limit with objective ischemia, plus angiographic confirmation of acute plaque rupture and intraluminal coronary thrombus in the culprit artery.\n\nD. Ischemic symptoms during tachyarrhythmia with an increased rate–pressure product $HR \\times SBP$ alone, regardless of Cardiac Troponin (cTn) dynamics, and without requiring exclusion of acute atherothrombosis.\n\nE. Rise and/or fall in Cardiac Troponin (cTn) above the $99^{\\mathrm{th}}$ percentile upper reference limit with objective ischemia, but only when there is a preexisting fixed epicardial coronary stenosis of $>70\\%$ on angiography documented prior to the event, irrespective of whether acute atherothrombosis is present.",
            "solution": "### Step 1: Extract Givens\n\nThe problem provides the following information and principles:\n- **Clinical Presentation:** An adult patient with acute chest discomfort, rapid supraventricular tachycardia, reduced hemoglobin ($[Hb]$), mild hypoxemia ($S_{a}O_2 < 1.0$), and transient ischemic ECG changes.\n- **Laboratory and Imaging Findings:**\n    - A rise and subsequent fall in Cardiac Troponin (cTn), with peak values above the $99^{\\mathrm{th}}$ percentile upper reference limit.\n    - No angiographic evidence of an acute coronary thrombus.\n- **Physiological Principles:**\n    - Myocardial oxygen delivery: $DO_2 = Q \\times C_{a}O_2$, where $Q$ is coronary blood flow and $C_{a}O_2$ is arterial oxygen content.\n    - Arterial oxygen content: $C_{a}O_2 = 1.34 \\times [Hb] \\times S_{a}O_2 + 0.003 \\times P_{a}O_2$.\n    - Myocardial oxygen consumption ($MVO_2$) is approximated by the rate–pressure product: $MVO_2 \\propto HR \\times SBP$.\n- **Pathophysiological Definitions:**\n    - Myocardial ischemia occurs when $MVO_2 > DO_2$.\n    - Myocardial infarction (MI) requires evidence of myocardial necrosis and ischemia.\n    - Evidence of myocardial necrosis is a rise and/or fall of cTn with at least one value above the $99^{\\mathrm{th}}$ percentile upper reference limit.\n    - Evidence of ischemia includes symptoms, ECG changes, or imaging evidence.\n- **MI Categories by Mechanism:**\n    1.  Acute coronary atherothrombosis (plaque rupture with intraluminal thrombus).\n    2.  A primary supply–demand mismatch without acute atherothrombosis.\n- **Illustrative Scenario:** A situation with $[Hb] = 8\\,\\mathrm{g/dL}$, $S_{a}O_2 = 0.90$, $P_{a}O_2 = 60\\,\\mathrm{mmHg}$, $HR = 160\\,\\mathrm{beats/min}$, and $SBP = 110\\,\\mathrm{mmHg}$ leading to reduced $C_{a}O_2$ and increased $HR \\times SBP$, with no acute thrombus, exemplifies the supply-demand mismatch mechanism.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement is evaluated against the established criteria:\n- **Scientifically Grounded:** The problem is based on fundamental principles of cardiovascular physiology (Fick's principle, determinants of oxygen supply and demand) and pathology (the universal definition of myocardial infarction). The formulas, definitions, and clinical scenario are standard and accurate within the field of cardiology.\n- **Well-Posed:** The problem clearly defines a specific category of myocardial infarction based on a mechanistic framework and asks to identify the correct enumeration of its diagnostic criteria. It provides all necessary information to logically deduce these criteria. The question is structured to lead to a single, correct answer based on synthesizing the provided information.\n- **Objective:** The language is technical, precise, and free of subjective or ambiguous terminology. It frames the question as a formalization of a diagnostic category based on established pathophysiology.\n\nThe problem statement does not violate any of the invalidity criteria. It is scientifically sound, well-posed, objective, complete, and relevant.\n\n### Step 3: Verdict and Action\n\nThe problem statement is **valid**. The solution will proceed by deriving the diagnostic criteria from the provided framework and evaluating each option.\n\n### Solution Derivation\n\nThe question asks for the diagnostic criteria for the category of myocardial infarction driven by a supply-demand mismatch without acute coronary atherothrombosis. This corresponds to what is clinically known as Type 2 Myocardial Infarction. We will construct the definition from the first principles given in the problem text.\n\n1.  **Core Requirement for MI:** The problem states, \"Myocardial infarction requires evidence of myocardial necrosis and ischemia.\"\n\n2.  **Defining Myocardial Necrosis:** The text specifies the evidence for necrosis: \"a rise and/or fall of Cardiac Troponin (cTn) with at least one value above the $99^{\\mathrm{th}}$ percentile upper reference limit.\" This establishes the mandatory biochemical criterion.\n\n3.  **Defining Myocardial Ischemia:** The text defines ischemia as the condition $MVO_2 > DO_2$. The evidence for this is stated as \"ischemic features (symptoms, ECG changes, or imaging evidence).\" The clinical scenario provides examples of these features (\"acute chest discomfort,\" \"transient ischemic changes\" on ECG).\n\n4.  **Defining the Specific Mechanism (Supply-Demand Mismatch):**\n    - The problem distinguishes this category from that of \"Acute coronary atherothrombosis.\" Therefore, a necessary criterion is the *absence* of acute atherothrombosis. The problem states, \"no angiographic evidence of an acute coronary thrombus.\"\n    - The underlying cause is a \"primary supply–demand mismatch.\" The framework and example illustrate how this mismatch arises from one or more precipitating conditions that either decrease oxygen supply ($DO_2$) or increase oxygen demand ($MVO_2$).\n    - **Decreased Supply:** Factors reducing $DO_2$ include a low arterial oxygen content ($C_{a}O_2$). The formula $C_{a}O_2 = 1.34 \\times [Hb] \\times S_{a}O_2 + 0.003 \\times P_{a}O_2$ shows that low hemoglobin ($[Hb]$, i.e., anemia) and low oxygen saturation ($S_{a}O_2$, i.e., hypoxemia) will reduce $C_{a}O_2$. A reduction in coronary blood flow ($Q$), for instance due to severe hypotension, would also decrease $DO_2$.\n    - **Increased Demand:** The proxy for myocardial oxygen consumption, $MVO_2$, is the rate-pressure product, $HR \\times SBP$. The example highlights a high heart rate ($HR=160\\,\\mathrm{beats/min}$, i.e., tachyarrhythmia) as a cause for increased demand. Severe hypertension (high $SBP$) would similarly increase demand.\n\n5.  **Synthesizing the Complete Criteria:**\n    A diagnosis of MI due to supply-demand mismatch without atherothrombosis requires the simultaneous presence of:\n    - **(a) Evidence of Myocardial Necrosis:** A rise and/or fall of cTn with a peak value >$99^{\\mathrm{th}}$ percentile.\n    - **(b) Evidence of Myocardial Ischemia:** Clinical signs such as symptoms, ECG changes, or imaging findings.\n    - **(c) Absence of Acute Atherothrombosis:** No evidence of acute plaque rupture or intraluminal thrombus.\n    - **(d) Presence of a Precipitating Condition:** Identification of an underlying condition that creates an imbalance between myocardial oxygen supply and demand (e.g., anemia, hypoxemia, tachyarrhythmia, hypotension, severe hypertension).\n\n### Option-by-Option Analysis\n\n- **Option A:** This option states the criteria as: (1) Rise and/or fall in cTn >$99^{\\mathrm{th}}$ percentile, (2) objective evidence of myocardial ischemia, (3) identification of a precipitating condition causing a supply-demand imbalance (with correct examples), and (4) absence of acute coronary atherothrombosis. This perfectly matches all four components (a, b, c, d) derived from the problem's first principles.\n  **Verdict: Correct**\n\n- **Option B:** This option describes a \"stable\" cTn elevation and states that ischemia is not required. The problem text explicitly requires a \"rise and/or fall\" (dynamic change) of cTn and evidence of \"ischemia\" for a diagnosis of MI. A stable troponin elevation without ischemia signifies chronic myocardial injury, not an acute myocardial infarction.\n  **Verdict: Incorrect**\n\n- **Option C:** This option describes an MI with \"angiographic confirmation of acute plaque rupture and intraluminal coronary thrombus.\" This is the definition of the *other* category of MI mentioned in the problem (Type 1 MI), which the question specifically asks to distinguish from. The problem context specifies \"no angiographic evidence of an acute coronary thrombus.\"\n  **Verdict: Incorrect**\n\n- **Option D:** This option suggests that ischemic symptoms and an increased rate-pressure product are sufficient, \"regardless of Cardiac Troponin (cTn) dynamics.\" This is incorrect because the definition of MI provided in the problem explicitly requires evidence of myocardial necrosis, which is defined by the cTn criteria. This option describes demand ischemia or unstable angina, not a confirmed MI.\n  **Verdict: Incorrect**\n\n- **Option E:** This option incorrectly restricts the diagnosis to patients with a pre-existing severe fixed stenosis ($>70\\%$) and incorrectly makes the presence of acute atherothrombosis irrelevant. A supply-demand MI can occur with or without significant underlying coronary artery disease. More importantly, the exclusion of acute atherothrombosis is a critical part of the definition, which this option dismisses.\n  **Verdict: Incorrect**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Cardiac troponin is the cornerstone biomarker for diagnosing myocardial infarction, but its interpretation requires careful consideration of the clinical context. This advanced practice addresses a common diagnostic dilemma: how to reliably detect an acute MI in a patient with chronically elevated troponin due to kidney disease. You will use a statistical model incorporating biological and analytical variation to define a significant change, demonstrating the quantitative rigor required in modern clinical pathology. ",
            "id": "4411746",
            "problem": "A clinician is evaluating a suspected acute myocardial infarction (MI) in a patient with Chronic Kidney Disease (CKD). Chronic Kidney Disease (CKD) is known to elevate baseline high-sensitivity cardiac troponin T (hs-cTnT) and to increase biological variability. To minimize false positives, the clinician wishes to set a decision threshold for the minimal absolute rise in hs-cTnT that must be exceeded between two serial measurements to confidently detect an acute injury on top of the chronic elevation.\n\nAssume the following scientifically grounded, widely accepted bases:\n- The measurement at any time is modeled as the sum of the true concentration and two independent sources of random variation: analytical imprecision and within-individual biological variation. Each source is assumed to be Gaussian (normal) with zero mean.\n- The coefficient of variation is defined as $CV = \\sigma / \\mu$, where $\\sigma$ is the standard deviation and $\\mu$ is the mean concentration. Analytical coefficient of variation and biological coefficient of variation combine as independent variances.\n- For two independent Gaussian measurements with the same mean, the variance of their difference equals the sum of their variances.\n\nIn this patient, the baseline hs-cTnT is at steady state with mean concentration $C_{\\text{base}} = 35$ ng/L. The analytical coefficient of variation at this concentration is $CV_{a} = 0.05$, and the CKD-associated within-individual biological coefficient of variation is $CV_{i} = 0.12$. Two samples are drawn $1$ hour apart, and a one-sided confidence requirement is chosen so that the probability of observing a rise that is due only to random variation (no acute injury) is $0.05$.\n\nUsing the bases above and treating the analytical and biological components as independent Gaussian variables, derive the minimal absolute rise threshold $\\Delta C^{\\ast}$ in ng/L such that a rise greater than $\\Delta C^{\\ast}$ has a one-sided false-positive probability of $0.05$ under the no-injury model. Express your final answer in ng/L and round to four significant figures.",
            "solution": "The user has asked for a critical validation and, if valid, a solution to the problem.\n\n### Step 1: Extract Givens\n- **Context**: Evaluating suspected acute myocardial infarction (MI) in a patient with Chronic Kidney Disease (CKD).\n- **Known Effects of CKD**: Elevates baseline high-sensitivity cardiac troponin T (hs-cTnT) and increases biological variability.\n- **Objective**: Determine the minimal absolute rise threshold, $\\Delta C^{\\ast}$, in hs-cTnT between two serial measurements to achieve a specified confidence level against false positives.\n- **Model Assumptions**:\n    1. A single measurement is the sum of the true concentration and two independent, zero-mean Gaussian random variations: analytical imprecision and within-individual biological variation.\n    2. The coefficient of variation ($CV$) is defined as $CV = \\sigma / \\mu$, where $\\sigma$ is the standard deviation and $\\mu$ is the mean concentration.\n    3. Analytical and biological variations combine as independent variances.\n    4. For two independent Gaussian measurements with the same mean, the variance of their difference is the sum of their variances.\n- **Patient-Specific Data**:\n    - Baseline mean hs-cTnT concentration: $C_{\\text{base}} = 35$ ng/L.\n    - Analytical coefficient of variation: $CV_{a} = 0.05$.\n    - Within-individual biological coefficient of variation: $CV_{i} = 0.12$.\n- **Measurement Protocol & Statistical Requirement**:\n    - Two samples are drawn $1$ hour apart.\n    - The one-sided false-positive probability for a rise due to random variation alone (no acute injury) is required to be $0.05$.\n- **Required Output**:\n    - The value of $\\Delta C^{\\ast}$ in ng/L.\n    - The final answer must be rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the validation criteria.\n\n- **Scientifically Grounded**: The problem is well-grounded in clinical chemistry and biostatistics. The model of measurement error (true value + random error components) is standard. The concepts of analytical precision ($CV_a$) and biological variation ($CV_i$) are fundamental to laboratory medicine, particularly for biomarkers like cardiac troponin. The values provided for $C_{\\text{base}}$, $CV_a$, and $CV_i$ are realistic for a patient with CKD being evaluated with a high-sensitivity troponin assay. The use of a Gaussian distribution to model variation is a common and appropriate approximation in this context.\n- **Well-Posed**: The problem is well-posed. It provides a clear objective (calculate $\\Delta C^{\\ast}$) and supplies all necessary quantitative data and a complete statistical model to arrive at a unique, meaningful solution.\n- **Objective**: The problem is stated in precise, objective, and quantitative terms, free from ambiguity or subjective content.\n- **Flaws Checklist**:\n    1. **Scientific/Factual Unsoundness**: None. The model and its premises are sound.\n    2. **Non-Formalizable/Irrelevant**: None. The problem is directly formalizable and highly relevant to the diagnosis of MI.\n    3. **Incomplete/Contradictory Setup**: None. All necessary information is provided.\n    4. **Unrealistic/Infeasible**: None. The parameters are within plausible ranges.\n    5. **Ill-Posed/Poorly Structured**: None. A unique solution can be derived.\n    6. **Pseudo-Profound/Trivial**: None. The problem requires a correct application of statistical principles of error propagation and hypothesis testing, which is a non-trivial task.\n    7. **Outside Scientific Verifiability**: None. The claims and methods are verifiable.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. A solution will be derived.\n\n### Solution Derivation\nThe objective is to find the minimal rise threshold, $\\Delta C^{\\ast}$, such that the probability of observing a change greater than $\\Delta C^{\\ast}$ due to random variation alone is $0.05$. This is framed under the null hypothesis ($H_0$) of no acute cardiac injury.\n\nUnder $H_0$, the patient's true hs-cTnT concentration remains at a steady state, $C_{\\text{base}}$. Let $C_1$ and $C_2$ be the two sequential measurements. Each measurement is a random variable. The total variation in a single measurement is the sum of the analytical variance ($\\sigma_a^2$) and the biological variance ($\\sigma_i^2$), as these sources are stated to be independent.\n\nThe standard deviations for the analytical and biological components are derived from their respective coefficients of variation ($CV$) at the mean concentration $C_{\\text{base}}$:\n- Analytical standard deviation: $\\sigma_a = CV_a \\cdot C_{\\text{base}}$\n- Biological standard deviation: $\\sigma_i = CV_i \\cdot C_{\\text{base}}$\n\nThe total variance for a single measurement, $\\sigma_{\\text{total}}^2$, is:\n$$ \\sigma_{\\text{total}}^2 = \\sigma_a^2 + \\sigma_i^2 = (CV_a \\cdot C_{\\text{base}})^2 + (CV_i \\cdot C_{\\text{base}})^2 = C_{\\text{base}}^2 (CV_a^2 + CV_i^2) $$\nUnder $H_0$, both measurements $C_1$ and $C_2$ are drawn from the same Gaussian distribution, $C_k \\sim N(\\mu=C_{\\text{base}}, \\sigma^2=\\sigma_{\\text{total}}^2)$.\n\nWe are interested in the difference between the two measurements, $\\Delta C = C_2 - C_1$. Since $C_1$ and $C_2$ are independent random variables, the distribution of their difference, $\\Delta C$, is also Gaussian.\nThe mean of the difference is:\n$$ E[\\Delta C] = E[C_2 - C_1] = E[C_2] - E[C_1] = C_{\\text{base}} - C_{\\text{base}} = 0 $$\nThe variance of the difference is the sum of the variances of the individual measurements:\n$$ \\text{Var}(\\Delta C) = \\sigma_{\\Delta C}^2 = \\text{Var}(C_2) + \\text{Var}(C_1) = \\sigma_{\\text{total}}^2 + \\sigma_{\\text{total}}^2 = 2\\sigma_{\\text{total}}^2 $$\nSubstituting the expression for $\\sigma_{\\text{total}}^2$:\n$$ \\sigma_{\\Delta C}^2 = 2 C_{\\text{base}}^2 (CV_a^2 + CV_i^2) $$\nThe standard deviation of the difference is therefore:\n$$ \\sigma_{\\Delta C} = \\sqrt{2 C_{\\text{base}}^2 (CV_a^2 + CV_i^2)} = C_{\\text{base}} \\sqrt{2(CV_a^2 + CV_i^2)} $$\nWe need to find the threshold $\\Delta C^{\\ast}$ such that the one-sided probability of exceeding this value is $0.05$:\n$$ P(\\Delta C > \\Delta C^{\\ast}) = 0.05 $$\nTo find this, we standardize the variable $\\Delta C$. Let $Z$ be a standard normal random variable, $Z \\sim N(0, 1)$.\n$$ Z = \\frac{\\Delta C - E[\\Delta C]}{\\sigma_{\\Delta C}} = \\frac{\\Delta C}{\\sigma_{\\Delta C}} $$\nThe condition becomes:\n$$ P\\left(Z > \\frac{\\Delta C^{\\ast}}{\\sigma_{\\Delta C}}\\right) = 0.05 $$\nLet $z_{\\alpha}$ denote the upper critical value of the standard normal distribution for a tail probability of $\\alpha$. For $\\alpha = 0.05$, the critical value $z_{0.05}$ is approximately $1.64485$.\nWe set:\n$$ \\frac{\\Delta C^{\\ast}}{\\sigma_{\\Delta C}} = z_{0.05} $$\n$$ \\Delta C^{\\ast} = z_{0.05} \\cdot \\sigma_{\\Delta C} $$\nSubstituting the expression for $\\sigma_{\\Delta C}$:\n$$ \\Delta C^{\\ast} = z_{0.05} \\cdot C_{\\text{base}} \\sqrt{2(CV_a^2 + CV_i^2)} $$\nNow, we substitute the given numerical values: $C_{\\text{base}} = 35$, $CV_a = 0.05$, and $CV_i = 0.12$.\n$$ CV_a^2 + CV_i^2 = (0.05)^2 + (0.12)^2 = 0.0025 + 0.0144 = 0.0169 $$\n$$ \\Delta C^{\\ast} = 1.64485 \\cdot 35 \\cdot \\sqrt{2(0.0169)} $$\n$$ \\Delta C^{\\ast} = 1.64485 \\cdot 35 \\cdot \\sqrt{0.0338} $$\n$$ \\Delta C^{\\ast} \\approx 1.64485 \\cdot 35 \\cdot 0.18384776 $$\n$$ \\Delta C^{\\ast} \\approx 57.56975 \\cdot 0.18384776 $$\n$$ \\Delta C^{\\ast} \\approx 10.58411 \\text{ ng/L} $$\nThe problem requires the answer to be rounded to four significant figures.\n$$ \\Delta C^{\\ast} \\approx 10.58 $$",
            "answer": "$$\\boxed{10.58}$$"
        }
    ]
}